Loading...
Loading...
PRME| Name | Value |
|---|---|
| Revenues | 37.8M |
| Cost of Revenue | 0.0M |
| Gross Profit | 37.8M |
| Operating Expense | 55.7M |
| Operating I/L | -55.7M |
| Other Income/Expense | 0.2M |
| Interest Income | 0.6M |
| Pretax | -55.5M |
| Income Tax Expense | -0.1M |
| Net Income/Loss | -55.3M |
Prime Medicine, Inc. is a biotechnology company specializing in genetic therapies using gene editing technology. The company offers Prime Editors, which consist of a fusion between a Cas protein and a reverse transcriptase enzyme, along with pegRNA to target specific genomic locations and facilitate DNA sequence edits. Prime Medicine generates revenue by providing these genetic therapies to address diseases through precise gene editing.
